Therapeutic Indications

Carbamazepine is indicated for:

Paroxysmal pain of trigeminal neuralgia

Irrespective of gender only Elderly (65 years old or older)

Carbamazepine is indicated for the paroxysmal pain of trigeminal neuralgia.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 200-1200 mg in 3-4 divided doses daily

Epilepsy

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old)

Carbamazepine is indicated for generalised tonic-clonic and partial seizures.

Carbamazepine is not usually effective in absences (petit mal) and myoclonic seizures. Moreover, anecdotal evidence suggests that seizure exacerbation may occur in patients with atypical absences.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 10-20 mg/kg in 2 divided doses daily

Treatment 2: Rectal - 100-1000 mg in 4 divided doses daily

Paroxysmal pain of trigeminal neuralgia

Irrespective of gender only Adults (18 - 65 years old)

Carbamazepine is indicated for the paroxysmal pain of trigeminal neuralgia.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 200-1600 mg in 3-4 divided doses daily

Prophylaxis of manic-depressive psychosis

Irrespective of gender only Adults (18 years old or older)

Carbamazepine is indicated for the prophylaxis of manic-depressive psychosis in patients unresponsive to lithium therapy.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 400-1600 mg in 2-3 divided doses daily

Epilepsy

Irrespective of gender only Adults (18 years old or older)

Carbamazepine is indicated for generalised tonic-clonic and partial seizures.

Carbamazepine is not usually effective in absences (petit mal) and myoclonic seizures. Moreover, anecdotal evidence suggests that seizure exacerbation may occur in patients with atypical absences.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 100-2000 mg in 2-3 divided doses daily

Treatment 2: Rectal - 100-1000 mg in 4 divided doses daily

Contraindications

Active ingredient Carbamazepine is contraindicated in the following cases:

Monoamine oxidase inhibitors (MAOIs)

No gender/age discrimination

Atrioventricular block

No gender/age discrimination

Acute intermittent porphyria

No gender/age discrimination

Bone marrow depression

No gender/age discrimination

Hepatic porphyria

No gender/age discrimination